Behavioral and pharmacologic approaches to smoking cessation

Cancer and Metastasis Reviews

Volumn 16, Issue 3-4, 1997, Pages 393-404

  Anderson, Cheryl B ^a   Wetter, David W ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Nicotine dependence; Smoking cessation

Indexed keywords

AMFEBUTAMONE; ANOREXIGENIC AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; BUSPIRONE; CLONIDINE; NICOTINE; NICOTINE GUM; PHENYLPROPANOLAMINE; PLACEBO;

ANXIETY; BEHAVIOR MODIFICATION; CIGARETTE SMOKING; CLINICAL TRIAL; DEPRESSION; HUMAN; INTRANASAL DRUG ADMINISTRATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROBLEM SOLVING; REVIEW; SELF HELP; SMOKING CESSATION; SOCIAL SUPPORT; SUBSTITUTION THERAPY; TRANSDERMAL DRUG ADMINISTRATION;

EID: 0030688925     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1023/a:1005816715064     Document Type: Review

References (65)

1. USDHHS. Reducing the health consequences of smoking: 25 Years of progress - A report of the Surgeon General. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, Centers for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 1989
2. CDC. Cigarette smoking among adults - United States, 1994. Morbidity and mortality weekly report 45: 588-590, 1996
3. CDC. Surveillance for selected tobacco-use behaviors -United States, 1900-1994. Morbidity and mortality weekly report 43: 1-43, 1994
4. Johnston-Early A, Cohen MH, Minna JD, Paxton LM, Fossieck BE Jr. Ihde DC, Bunn PA Jr, Matthews MJ, Makuch R: Smoking abstinence and small cell lung cancer survival. J Am Med Assoc 244: 2175-2179, 1980
5. Silverman S, Gorsky M, Greenspan D: Tobacco usage in patients with head and neck carcinomas: A follow-up study on habit changes and second primary oral/oropharyngeal cancers. J Am Dental Assoc 106: 33-35, 1983
6. Browman GP, Wong G, Hodson I et al.: Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. N Engl J Med 328: 159-163, 1993
7. Gritz ER, Kristeller J, Burns DM: High risk groups and patients with medical co-morbidity. In: Orleans CT, Slade J (eds) Nicotine Addiction: Principles and Management. Oxford University Press, New York, 1993, pp 279-309
8. Moore C: Cigarette smoking and cancer of the mouth, pharynx and larynx. J Am Med Assoc 218: 553-558, 1971
9. Stevens MH, Gardner JW, Parkin JL, Johnson LP: Head and neck cancer survival and lifestyle change. Arch Otolaryngol 109: 746-749, 1983
10. UDSHHS: The health benefits of smoking cessation: A report of the Surgeon General Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, Centers for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 1990
11. Emmons KM, Goldstein MG: Smokers who are hospitalized: A window of opportunity for cessation interventions. Preventive Medicine 21: 262-269, 1992
12. USDHHS. The health consequences of smoking: Nicotine Addiction - a report of the Surgeon General. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, Centers for Health Promotion and Education, Office on Smoking and Health, 1988
13. CDC. Cigarette smoking among adults - United States, 1991. Morbidity and Mortality Weekly Report 42 (12): 230-233, 1993
14. CDC. Health-care provider advice on tobacco use to persons aged 10-22 years - United States, 1993. Morbidity and Mortality Weekly Report 44: 826-830, 1995
15. Fiore MC, Bailey WC, Cohen SJ et al.: Smoking cessation. Clinical Practice Guideline No. 18. Rockville, MD: USDHHS, Public Health Service, Agency for Health Care Policy and Research. AHCPR Publication No. 96-0692, 1996
16. Fiore MC, Baker TB: Smoking cessation treatment on the good doctor club. Amer J Public Health 85: 161-163, 1995
17. Fiore MC, Novotny TE, Pierce JP et al.: Methods used to quit smoking in the United States. J Am Med Assoc 263: 2760-2765, 1990
18. Strecher VJ, Kreuter M, Boer D, Hospers KS, Skinner CS: The effects of computer-tailored smoking cessation messages in family practice settings. J Family Prac 39: 262-270, 1994
19. Prochaska JO, DiClementee CC, Velicer WF, Rossi JS: Standardized, individualized, interactive, and personalized self-help programs for smoking cessation. Health Psychol 12: 399-405, 1993
20. Curry SJ, McBride C, Grothaus LC, Louie D, Wagner EH: A randomized trial of self-help materials, personalized feedback, and telephone counseling with nonvolunteer smokers. J Consult Clin Psychol 63: 1005-1014, 1995
21. Cinciripini PM, Lapitsky LG, Seay S, Wallfish A, Kitchens K, Van Vunakis H: The effects of smoking schedules on cessation outcome: Can we improve on common methods of gradual and abrupt nicotine withdrawal. J Consult Clin Psychol 63: 388-399, 1995
22. Schwartz JL: Review and evaluation of smoking cessation methods: The United States and Canada, 1978-1985 (Report No. 81-2940). US Public Health Service, Besthesda, MD, 1987
23. Zhu SH, Stretch V, Balabanis M, Rosbrook B, Sadler G, Pierce JP: Telephone counseling for smoking cessation -Effects of single-session and multiple-session interventions. J Consult Clinic Psychol 64 (1): 202-211, 1996
24. Brandon TH, Copeland AL, Saper ZL: Programmed therapeutic messages as a smoking treatment adjunct: Reducing the impact of negative affect. Health Psychol 14 (1): 41-47, 1995
25. Fiore MC, Smith SS, Jorenby DE, Baker TB: The effectiveness of nicotine patch for smoking cessation. J Amer Med Assoc 271: 1940-1947, 1994
26. Gourlay S: The pros and cons of transdermal nicotine therapy. Med Jn Australia 160: 152-159, 1994
27. Po ALW: Transdermal nicotine in smoking cessation: A meta-analysis. Eur J Clin Pharmacol 45: 519-528, 1993
28. Silagy C, Mant D, Fowler G, Lodge M: Meta-analysis on efficacy of nicotine replacement therapies in smoking cessation. Lancet 343: 139-142, 1994
29. Tang JL, Law M, Wald N: How effective is nicotine replacement therapy in helping people to stop smoking? Brit Med J 308: 21-26, 1994
30. Jorenby DE, Smith SS, Fiore MC, Hurt RD, Offord KP, Croghan I, Hays JT, Lewis SF, Baker TB: Varying nicotine patch dose and type of smoking cessation counseling. JAMA 274: 1347-1352, 1995
31. Dale LC, Hurt RD, Offord KP, Lawson GM: High-dose nicotine patch therapy: Percentage of replacement and smoking cessation. JAMA 274: 1353-1358, 1995
32. Cepeda-Benito: A meta-analytic review of the efficacy of nicotine chewing gum in smoking treatment programs. J Consult Clin Psychol 61: 822-830, 1993
33. Lam W, Sze PC, Sacks HS, Chalmers TC: Meta-analysis of randomized controlled trials of nicotine gum. Lancet 2: 27-30, 1987
34. Hajek P, Jackson P, Belcher M: Long-term use of nicotine chewing gum. JAMA 260: 2593-2596, 1988
35. Hughes JR, Wadland WC, Fenwick JW, Lewis J, Bickel WK: Effect of cost on the self-administration and efficacy of nicotine gum: A preliminary study. Preventive Med 20: 186-196, 1991
36. Benowitz NL, Jacob P 3rd, Savanapridi C: Determinants of nicotine intake while chewing nicotine polacrilex gum. Clin Pharmacol Ther 41 (4): 467-473, 1987
37. Fagerstrom KO, Sawe U: The pathophysiology of nicotine dependence: Treatment options and the cardiovascular safety of nicotine. Cardiovascular Risk Factors 6: 135-143, 1996
38. Sutherland G, Stapleton JA, Russell MAH et al.: Randomized controlled trial of nasal nicotine spray in smoking cessation. Lancet 340: 324-329, 1992
39. Schneider NG, Lunell E, Olmstead RE, Fagerstrom KO: Clinical pharmacokinetics of nasal nicotine delivery: A review and comparison to other nicotine systems. Clin Pharmacokinet 31: 65-80, 1996
40. Schneider NG, Olmtead R, Mody F, Doan K, Franzon M, Jarvik ME, Steinberg C: Efficacy of a nasal nicotine spray in smoking cessation: A placebo-controlled, double-blind trial. Addiction 90: 1671-1682, 1995
41. Tonnesen P, Norregaard J, Mikkelsen K, Jorgensen S, Nilsson FA: A doubleblind trial of a nicotine inhaler for smoking cessation. J Am Med Assoc 269: 1268-1271, 1993
42. Leischow SJ, Nilsson F, Franzon M, Hill A, Otte P, Merikle EP: Efficacy of the nicotine inhaler as an adjunct to smoking cessation. Am J Health Behavior 20: 364-374, 1996
43. Schneider NG, Jarvik ME, Forsythe AB: Nicotine vs. placebo gum in the alleviation of withdrawal during smoking cessation. Addict Behav 9: 149-156, 1984
44. Hughes JR, Higgins ST, Hatsukami DK: Effects of abstinence from tobacco: A critical review. In: Kozlowski H, Annis H, Cappell HD, Glaser F, Goodstadt M, Isreal Y, Kalant H, Sellers EM, Vingilis J (eds) Research Advances in Alcohol and Drug Problems, vol. 10. Plenum Press, New York, 1990, pp 317-398
45. West RJ: The 'nicotine replacement paradox' in smoking cessation: How does nicotine gum really work? Br J Addict 87: 165-167, 1992
46. Hughes JR: Pharmacotherapy for smoking cessation: Unvalidated assumption, anomalies, and suggestions for future research. J Consult Clin Psychol 61 (5): 751-760, 1993
47. Fagerstrom KO: Combined use of nicotine replacement products. Health Values 18: 15-20, 1994
48. Komitzer M, Bousten M, Dramaix M, Thijs J, Gustavsson G: Combined use of nicotine patch and gum in smoking cessation: A placebo-controlled clinical trial. Prev Med 24: 41-47, 1995
49. Puska P, Korhonen HJ, Vartiainen E, Urjanheimo EL, Gustavsson G, Westin A: Combined use of nicotine patch and gum compared with gum alone in smoking cessation: A clinical trial in North Karelia. Tobacco Control 4: 231-235, 1995
50. Dalack GW, Glassman AH, Rivelli S, Covey L, Stetner F: Mood, major depression, and fluoxetine response in cigarette smokers. Am J Psychiatry 152: 398-403, 1995
51. Glassman AH: Cigarette smoking: Implications for psychiatric illness. Am J Psychiatry 150: 546-553, 1993
52. Ferry LH, Robbins AS, Scariati PD, Masterson A, Abbey DE, Burchette RJ: Enhancement of smoking cessation using the antidepressant bupropion hydrochloride (abstract). Circulation 86: 671, 1992
53. Ferry LH, Burchette RJ: Evaluation of bupropion versus placebo for treatment of nicotine dependence, in New Research Program and Abstracts. 147th Annual Meeting of the Am Psychiatric Assoc, Washington, DC. APA, 1994, pp 199-200
54. Breslau N, Kilbey MM, Andreski P: Nicotine dependence, major depression, and anxiety in young adults. Arch Gen Psychiatry 48: 1069-1074, 1991
55. Kendler KS, Neale MC, MacLean CJ, Heath AC, Eaves LJ et al.: Smoking and major depression. Arch Gen Psychiatry 50: 36-43, 1993
56. Cinciripini PM, Lapitsky L, Seay S, Wallfisch A, Meyer WJ 3rd, van Vunakis H. A placebo-controlled evaluation of the effects of buspirone on smoking cessation: Differences between high-and low-anxiety smokers. J Clin Psychopharmacol 15 (3): 182-191, 1995
57. West R, Hajek P, McNeill A: Effect of buspirone on cigarette withdrawal symptoms and short-term abstinence rates in a smokers clinic. Psychopharmacology 104: 91-96, 1991
58. Robinson MD, Pettice YL, Smith WA et al.: Buspirone effect on tobacco withdrawal symptoms: A randomized placebo-controlled trial. J Am Board of Family Practice 5: 1-9, 1992
59. Schwartz JL, Dubitsky M: One-year follow-up results of a smoking cessation program. Canadian Jn Public Health 59: 161-165, 1968
60. Wei H, Young D: Effect of clonidine on cigarette cessation and in the alleviation of withdrawal symptoms. Brit J Addiction 83 (10): 1221-1226, 1988
61. Glassman AH, Covey LS, Dalack GW, Stetner F, Rivelli SK, Fleiss J, Cooper TB: Smoking cessation, clonidine, and vulnerability to nicotine among dependent smokers. Clin Pharmacol Ther 54 (6): 670-679, 1993
62. Klesges RC, Klesges LM, DeBon M, Shelton ML, Isbell TR, Klem ML: Effects of phenylpropanolamine on withdrawal symptoms. Psychopharmacology 119 (1): 85-91, 1995
63. Jaen CR, Stange KC, Nutting PA: Competing demands of primary care: A model for the delivery of clinical preventive services. J Fam Pract 38: 166-171, 1994
64. Wells KB, Lewis CE, Leake B, Schleiter MK, Brook RH: The practices of general and subspecially internists in counseling about smoking and exercise. Am J Public Health 76: 1009-1013, 1986
65. US Department of Health and Human Services. Healthy-People 2000, midcourse review and 1995 revisions. Washington (DC): US Department of Health and Human Services, Public Health Service, 1995